[The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
Bone metastasis is a frequent complication of malignant cancer. Previous clinical trials of bone metastasis have largely focused on skeletal related events (SREs) as objective end-points. However, a subjective health-related outcome such as quality of life (QOL) is also a first-priority principle for all patients with malignant cancer. In response to the need for a comprehensive module to evaluate bone metastasis-specific QOL, the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group has developed a Quality of Life Questionnaire for patients with Bone Metastases (EORTC QLQ-BM22). In this study, we introduce the official Japanese version of the EORTC QLQ-BM22 as a module to evaluate QOL in patients with bone metastasis. This module has been developed to be used together with the EORTC QLQ-C30, a QOL scale for patients with cancer, or with its shortened version, EORTC QLQ-C-15-PAL.
Satoh
Takefumi
T
Dept. of Urology, Kitasato University School of Medicine.
Kobayashi
Kunihiko
K
Hori
Taisuke
T
Iida
Shinsuke
S
Sato
Atsushi
A
Ishiguro
Hiroshi
H
Chow
Edward
E
Shimozuma
Kojiro
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D044466:Asian People; D001859:Bone Neoplasms / Q000523:psychology* / Q000556:secondary*; D003431:Cross-Cultural Comparison; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000473:pathology / Q000523:psychology; D011788:Quality of Life; D011795:Surveys and Questionnaires